Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Karolinska Institutet
UNICANCER
City of Hope Medical Center
Cardarelli Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Fox Chase Cancer Center
Ohio State University Comprehensive Cancer Center
University of Chicago
Case Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Ohio State University Comprehensive Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Groupe Oncologie Radiotherapie Tete et Cou
OHSU Knight Cancer Institute
Radiation Therapy Oncology Group
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)